Back to search

Article

Hyper Production of Anti Spike Antibodies and Rheumatological Manifestations: Coincidence or Pathogenesis?

2025-09-10

Abstract excerpt

<h4>Introduction: </h4> Vaccine is the most widely used public health measure to control the global COVID-19 pandemic. Most of the vaccines used in Europe and North America are mRNA-based vaccine A mass vaccination campaign was carried out between 2021 and 2024. Some adverse events have been reported. We question the role of vaccines in the pathogenesis of rheumatological manifestations observed following one or m...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e373ac2c-9e09-5a82-b4dd-adfc141d525f
DOI
10.20944/preprints202509.0688.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Hyper Production of Anti Spike Antibodies and Rheumatological Manifestations: Coincidence or Pathogenesis?DOI 10.20944/preprints202509.0688.v1
Knee Arthritis After COVID-19 Vaccination: A Seven-Cases SeriesSemantic proximity
Post-acute COVID-19 in three doses vaccinated autoimmune rheumatic diseases patients: frequency and pattern of this conditionSemantic proximity
Persistent Spike antigenemia is not associated with Post-COVID conditionSemantic proximity
Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patientsSemantic proximity
The Impact of The COVID-19 Pandemic on The Incidence of Adult and Pediatric Inflammatory ArthritisSemantic proximity
Serum Biomarker Profile Orchestrating the Seroconversion Status of Patients With Autoimmune Diseases Upon Planned Primary&nbsp;17DD Yellow Fever VaccinationSemantic proximity
Anti-SARS-CoV-2 immunogenicity decay and incident cases six months after Sinovac-CoronaVac inactivated vaccine in autoimmune rheumatic diseases patients: phase 4 prospective trialSemantic proximity
Myosin 16 mimicries may explain post- COVID-19 related neurological consequencesSemantic proximity
Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following Two‐Dose SARS – CoV ‐2 Messenger RNA VaccinationSemantic proximity
Molecular Mimicry of SARS-CoV-2 Spike Protein in the Nervous System: A Bioinformatics ApproachSemantic proximity
Immuno-inflammatory rheumatic diseases and COVID-19: analysis of clinical outcomes according to the data of the register of patients of the Novosibirsk region receiving therapy with genetically engineered biological drugsSemantic proximity
Zebrafish studies on the vaccine candidate to COVID-19, the Spike protein: Production of antibody and adverse reactionSemantic proximity
Select a neighboring publication to make it the new centre.